cgp 361a has been researched along with 5-hydroxytryptophan in 2 studies
| Studies (cgp 361a) | Trials (cgp 361a) | Recent Studies (post-2010) (cgp 361a) | Studies (5-hydroxytryptophan) | Trials (5-hydroxytryptophan) | Recent Studies (post-2010) (5-hydroxytryptophan) |
|---|---|---|---|---|---|
| 21 | 3 | 3 | 4,177 | 157 | 298 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, PA; Bischoff, S; Neale, RF; Sills, MA; Waldmeier, PC; Williams, M | 1 |
| Ahlenius, S; Kaur, P | 1 |
2 other study(ies) available for cgp 361a and 5-hydroxytryptophan
| Article | Year |
|---|---|
Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Brain; Cerebral Cortex; Corpus Striatum; Electric Stimulation; Hippocampus; In Vitro Techniques; Iodocyanopindolol; Male; Pindolol; Propanolamines; Rats; Receptors, Serotonin; Reserpine; Serotonin; Stereoisomerism; Tetrahydronaphthalenes | 1988 |
Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Betaxolol; Biogenic Monoamines; Dihydroxyphenylalanine; Drug Synergism; Indophenol; Male; Motor Activity; Pindolol; Piperazines; Piperidines; Propanolamines; Prosencephalon; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, beta; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reserpine; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |